Hemodialysis in 20 kg Patient with AKI and Sepsis

Slides:



Advertisements
Similar presentations
Neonatal and Infant CRRT
Advertisements

Norma J Maxvold Pediatric Critical Care
Renal Replacement Therapy Options for Children
CRRT Continue Renal Replacement Therapy
Dialysis in the Critically Ill
Pediatric CRRT: Terminology and Physiology
Hemodiafiltration and Hemofiltration
So how do I dose this drug “X” Timothy E Bunchman
1. 2 History Dialysis is a Greek word meaning "loosening from something else". Dialysis is referred to as "selective diffusion”. Diffusion is the movement.
MANAGEMENT OF CONTINUOUS HEMODIALYSIS
EDWARD WELSH MARCH Dialysis Adequacy (?).
Continuous Renal Replacement Therapy. Why continuous Therapies? Continuous therapies closely mimic the GFR of native kidneys Large amounts of fluid.
A E UROPEAN R ENAL B EST P RACTICE (ERBP) POSITION STATEMENT ON THE K IDNEY D ISEASE I MPROVING G LOBAL O UTCOMES (KDIGO) C LINICAL P RACTICE G UIDELINES.
Strategies for Improving Adequacy Decreasing the Risk of Premature Death Educate Your Dialysis Team Review Proper Procedure for Drawing Lab Samples - Lab.
HEMODIALYSIS ADEQUACY HEMODIALYSIS ADEQUACY Laurie Vinci RN, BSN, CNN Laurie Vinci RN, BSN, CNN September 17, 2011 September 17, 2011.
Elimination of Phosphate in HD and PD Reference: Kuhlmann MK. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis. Blood Purif.
Dr Umut Selda Bayrakçı Yıldırım Beyazıt University, Dept of Pediatric Nephrology, Ankara, Turkey * Basics of CRRT Terminology.
Troubleshooting Issues in CVVH Timothy L. Kudelka RN, BSN Pediatric Dialysis Program C.S. Mott Children’s Hospital University of Michigan.
Acute kidney injury R3 李岳庭 / F1 王奕淳 / VS 林景坤 Brenner and Rector's The Kidney, 8th ed P 高雄長庚腎臟科 Journal reading.
RENAL REPLACEMENT THERAPY
PRINCIPLES OF DIALYSIS DR SAAD ALSHOHAIB ASSOCIATE PROFESSOR IN MEDICINE AND NEPHROLOGY KAUH.
Matthew L. Paden, MD Division of Pediatric Critical Care
Vascular Access for CRRT Timothy E Bunchman Professor & Director Helen DeVos Children’s Hospital Grand Rapids, MI (Thanks to Rick Hackbarth MD for his.
Pediatric CRRT: The Prescription
ANTICOAGULATION IN CONTINUOUS RENAL REPLACEMENT THERAPY Dawn M Eding RN BSN CCRN Pediatric Critical Care Helen DeVos Children's Hospital.
The Clinical Guide “A Guide to Implementing Renal Best Practice in Haemodialysis“ Chapter 5: Anticoagulation Team Leader: Angela Henson Co-authors: Franta.
Pediatric CRRT: The Prescription Stuart L. Goldstein, MD Associate Professor of Pediatrics Baylor College of Medicine.
Practical Considerations for CRRT Helen Currier RN, BSN, CNN Nancy McAfee RN, BSN, CNN.
Anticoagulation in CRRT
Access in Pediatric CRRT
PCRRT PRESCRIPTIONS in ARF Patrick D. Brophy MD University of Michigan Pediatric Nephrology.
Renal Replacement Therapy in Intoxications Maria Ferris, MD, MPH, PhD University of North Carolina Kidney Center Chapel Hill, North Carolina USA 7/17/2015.
Sustained Low Efficiency Dialysis
Common Prescription Errors in Pediatric CRRT: a “Top 10 List” Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital.
University of Pittsburgh
David Askenazi MD, MSPH Associate Professor of Pediatrics 2Smaller Circuits for Smaller Patients Improving Renal Support with Aquadex™ Machine.
Common Terminology Used and Physiology in CRRT Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital Seattle, WA.
Complications of Pediatric CRRT Theresa A. Mottes RN Pediatric Dialysis/Research Nurse C.S. Mott Children’s Hospital University of Michigan.
PCRRT Multi-Center Registry Data Effective April 1, 2002 Multi-Center Pediatric CRRT Registry Stuart L. Goldstein, MD Assistant Professor of Pediatrics.
Proposal of a flow-chart to avoid circuit clotting in prolonged intermittent renal replacement therapy (PIRRT): a monocentric experience 1 Vincenzo Cantaluppi,
PCRRT Tûr'mə-nŏl'ə-jē Helen Currier BSN, RN, CNN Assistant Director, Renal/Pheresis Texas Children’s Hospital Houston, Texas.
Cytokine and Soluble Fas Ligand Response in Children with Septic Acute Renal Failure (ARF) on CVVH Paden ML, Fortenberry JD, Rigby MR, Trexler AM, Heard.
Continuous Renal Replacement Therapy Developed by: Critical Care and Hemodialysis Educators, February 2009 King Faisal Specialist Hospital and Research.
1 Profiling Conductivity. 2 Cellular Solute/Fluid Exchange Gambro Basics 1 (1994) All the membranes are semi-permeable allowing water to move freely between.
Hemodiafiltration: Clinical Evidence of Higher Benefit Reference: Blankestijn PJ, LedeboI, Canaud B. Hemodiafiltration: Clinical evidence and remaining.
Rajeev Annigeri. Apollo Hospitals, Chennai.
CRRT TERMINOLOGY Stefano Picca, MD
World Kidney Day 2016: Kidney Disease & Children
CONTINUOUS RENAL REPLACEMENT THERAPY
Continuous renal replacement therapy
CRRT Fundamentals Pre- and Post- Test
University of Alabama at Birmingham
CRRT (Continuous Renal Replacement Therapy)
HAEMODIALYSIS Shofa chasani.
Access for Pediatric CRRT
Quantification and Dosing of Renal Replacement Therapy in Acute Kidney Injury: A Reappraisal Blood Purif 2017;44: DOI: / Fig.
ANTICUAGULANT A.Rahimzadeh.B.sc,M.sc Shahid Beheshty university
Spotlight on general principles of hemodialysis
Shiraz Medical University
Devices use for Neonatal AKI
Prescriptions in CRRT Timothy E Bunchman MD Professor & Director
Vascular Access and Infused Fluids for Pediatric CRRT
Practical Considerations for CRRT
6/18/2018 Intensive Care; Acute Renal Failure 1 Continuous Renal Replacement Therapy (CRRT) Maureen Walter,Raquel Lomeli Anika Stevenson,Nellie Preble.
OUTCOMES OF REGIONAL CITRATE ANTICOAGULATION (RCA) IN PEDIARTIC CONTINUOUS RENAL REPLACEMENT THERAPY (pCRRT) IN A SINGLE CENTER Issa Alhamoud, Diane Gollhofer,
Andrew Durward St Thomas NHS Foundation Trust Orlando 2017 CRRT IN AKI.
Pediatric CRRT Terminology
Basics of CRRT: Terminology
Children’s Memorial Hospital Northwestern University
Case 20 kg child with sepsis and oliguria on norepinephrine with a BP of 95/45 Vent at 70% FIO2 and a PEEP of 8 FO at 15% K of 6 meq/dl and a BUN of 100.
Presentation transcript:

Hemodialysis in 20 kg Patient with AKI and Sepsis

Practicality and Flexibility of Application IRRT also allows more liberty for patient care and investigations outside the treatment and monitoring unit, by offering a dialysis-free period, without loss of dialysis time or adequacy IRRT machines can be used in an extended protracted mode when needed, and the treatment time can be decreased coupled to an increase in efficacy when the condition of the patient improves CRRT machines, do not allow an increase of the intensity of the treatment to allow shorter treatments Crit Care 2010, 14:R46

PD is available 100% in developing and developed country What to Choose? PD is available 100% in developing and developed country Modality Developed Country Developing country HD 85 % 54% P=.001 CRRT 60% 33 % SLED 20% 25% P=0.45 Raina et al. PLoS ONE 12(5): e0178233.

Modality of Choices Raina et al. PLoS ONE 12(5): e0178233.

Limitation of Expenses Median difference was US$289.6 per day in disfavor of CRRT ;The main differences attributed to fluid replacement and the extracorporeal circuit; reducing the substitution volume to <25 ml/minute/kg, diminished cost only by US$67.2 per day

Pediatric Acute Renal failure: Outcome by Modality and Disease Low BP at onset of RRT (33% vs 61% with nl BP, vs 100% with high BP; P<0.05) Use of pressors anytime during RRT ( survival 35% vs 89; P<0.01) Diagnosis (primary renal failure with a high likelihood of survival vs secondary renal failure) RRT modality (40% survival with HF, vs 49% survival with PD, vs 81% survival with HD) Pressor use was significantly higher in children on HF (74%) vs HD (33%) or PD (81%) Ped Neph 2001, Volume 16,iss 12; pp 1067-71

pCRRT slide London 2015

Caveats to CRRT No evidence from randomized trials to support survival advantage Risk of complications related to anticoagulation is higher Training and equipment costs 9

Comparison of Solute Clearance in three modes of CRRT CVVHD was superior to predilution CVVH for CL of urea and Cr Qb~ 60 mL/min While predilution or dialysate was run at 16.7% :33% :50% Qb CVVHD had a superior clearance 15% greater clearance at 1200 and 1800 mL/hr (P<0.05) and 10% at 600ml/hr PCCM: May 2004, Volume 5, Issue 3 – pp 269-274

Solute Removal: Is convective Mode is better Than Diffusive Clearances? CRRT promotes solute removal due to better mobilization from extra-plasmatic compartments More down time with CRRT vs IRRT due to filter exchange ? But higher intensity of solute removal leads to greater removal of drugs resulting in inadequate drug concentrations (for example, of antimicrobials) or more electrolyte disturbances Removal of cytokines and other large molecules can be obtained just as well, if not better, with IRRT or SLEDD, with large pore size (so-called high-flux membranes) No survival advantage of more efficient removal over standard removal. Intensive Care Med 1997, 23:288-296 and Crit Care Med 2010, 38:1360-1369

Hemodynamic Stability and Fluid Removal If there is a hemodynamic benefit for CRRT, this nevertheless is not translated into differences of survival Clinical hemodynamic parameter that was significantly higher with CRRT than with IRRT; the number of hypotension episodes was not different. However, potentially blurring the results of RCTs comparing CRRT and IRRT is the reluctance for including patients with major hemodynamic problems

Power Tools for Acute Hemodialysis not Too TrickyvTricks… … Power Tools for Acute Hemodialysis not Too TrickyvTricks… …..I am not dealing with old Hemodialysis Machine Blood volume continuous monitoring (BVM) : refilling capacity test, secured and optimized UF Blood thermal monitoring (BTM) : vascular stability, regional blood flow potential impact HDF procedure : allowed sequential UF, HF, HD, adapted to the individual patient needs, and evolution; on-line HDF provide for the restitution- hemofiltration fluid (possibility for adapted sodium concentration) Profiled prescriptions: UFrate at the best intermittent (refilling time), NaD not too high (interstitial storage, edema) Clearance and dialysis dose measurement, dialysis efficiency: slow (urea osmotic tolerance) but controlled purification (potassium gradient)

Pediatric Intradialytic Hypotension: A Systematic Review N=148 (2 days – 18yr), (3.2 to 61.4 kg) Incidence of IDH ranged (19.6% - 75%) with lower percentages who received NIVM during HD (implemented 65%) Of the protective maneuver tested Linear NaM, HNA, NIVM and low temp 35.5-35 were effective in reducing IDH but NIVM was favored by some plurality Sequential UF was not effective in reducing IDH Raina et al. Poster presentation pCRRT

Drug Clearance by CRRT Most important factor: effluent volume (determined by flow rate and therapy duration)1 Effluent rates have significantly increased compared to prior recommendation, eg “Drug Prescribing in Renal Failure”, 2007 ed. Assumes CRRT effluent rate of only 2 L/H2 Calculated CRRT dosing charts may be Outdated due to increased flow rates and efficiency of newer dialyzers3 Variability in published recommendations  potential underdosing in CRRT Mueller BA, et al. Organs 2003 Aronoff GR, et al. Drug prescribing in renal failures: dosing guidelines, 2007, ACP Heintz BH, et al. 2009, Pharmacotherapy

Restriction of Bleeding Complications CRRT Citrate option depends on skilled personnel and any mistake or technical problem may have grave consequences, such as life-threatening hypocalcemia- Crit Care Med 2009, 37:545-552 Bleeding complications were more frequent in the CRRT group and were the major reason for switching modalities from CRRT to IRRT- Curr Opin Nephrol Hypertens 1999, 8:701-707 Filter clotting tends to occur more frequently with CRRT than with IRRT 51% vs 22% (p<0.001)- Int. J Artif Organs 2004:;27(5):371-9 IRRT had less need for anticoagulation, and patients could be treated without coagulation at all

Dialysis Circuit Heparin Pump Blood Pump Arterial Pressure Monitor Dialysate Pump Dialysis Access Venous Pressure Monitor Air Trap Femoral Vein Ultrafiltrate Dialysate

Dialyzers Dialyzer Membrane SA (m2) Prime Volume (ml) KUf Pt Weight (kg) F3 PS 0.4 28 1.7 10-15 F4 0.7 42 2.8 15-25 F6 1.3 82 5.5 25-35 F160 1.5 83 50 35-80 F180 1.8 99 48 > 80 B 190 Xebium PES 1.9 114 75   B 150 CET 95 3.15 (hypoallergenic)

Dialysate composition Dialyzer Type Determined by patient size and Clearance and UF needs Tubing Type In patients < 10 kg, use neonatal tubing with blood pump set at 2.6 mm. 10-20 kg, use pediatric tubing with blood pump set at 6.4 mm. > 20 kg, use adult tubing with blood pump set at 8 mm. Priming of system For circuits with extracorporeal volume > 10% of patient blood volume (> 80ml/kg), diluted pRBC or whole blood circuit priming Dialysate composition Composition determined on a per-patient basis Dialysate flow Flow < 200 ml/min for infants/ small children Dialysate Temp To avoid hypothermia may be elevated to 37.5° C To prevent hypotension may be lowered to 35° C Blood Flow Rate (BF) Gradually increase over first 3-5 treatments: 1st treatment: BF = 2-3 ml/kg/min 2nd treatment: BF = 3-4 ml/kg/min 3rd treatment: BF = 4-5 ml/kg/min

Blood Priming If the extracorporeal volume (tubing volume + dialyzer volume) exceeds 10% of the patient’s estimated blood volume (> 80 ml/kg), consider priming the circuit with blood to prevent instability when initiating hemodialysis) This usually applies to children weighing less than 10 kg

Blood Priming Diluted PRBC (hematocrit 35%) that has been typed and cross-matched with the patient. Prime the circuit per routine, using normal saline Inject 2 units of heparin per ml into the diluted PRBCs. Prime the dialysis circuit with the diluted PRBCs. Allow the system to recirculate for 5 minutes to heparinization it and to warm the blood to an appropriate level for the patient. In any child in whom a blood prime is used, give the entire blood prime by connecting the arterial and venous lines simultaneously In patients 10-15 kg or hemodynamically unstable patients, give half or all of the prime In patients > 15 kg who are hemodynamically stable, do not give the prime.

Urea Reduction 30% reduction in first session 50% reduction in second session 70% afterwards UF goals No more than 5% of patient body weight removed during 3-4 hour session Anticoagulation For continuous heparinization of patients < 10kg, consider loading dose of 10 – 15 units/kg, with a maintenance dose of 10 – 25 units/kg/hour For routine heparinization of all low risk dialysis patients, consider total heparin dose of 25 units/kg/hours of dialysis   For patients at slight to moderate risk of bleeding (such as those with recent surgery with low bleeding risk, pericarditis, and/or Coumadin therapy), consider total heparin = 10 units/kg/hours of dialysis Medications Administered via infusion pump connected to venous port or IV push Blood transfusion Advantageous to transfuse blood during dialysis to reduce volume overload and hyperkalemia risk

Patient monitoring/Management of Hypotension Vital signs q 30 minutes Crit-line monitoring and/or Linear NaM and Cooling of dialysate increase vascular tone and support BP. Prior to initiating dialysis, orders should be in place for treatment of hypotension unresponsive to adjustment in UF goal per Crit-line. Saline bolus: 5 ml/kg 25% albumin 0.25 gm/kg, maximum 12.5 gm Mannitol 0.25 gm/kg, maximum 12.5 gm. no more frequently than q 1 hr. Not he last hour of treatment. Vasopressor support to correct dialysis-associated hypotension.

HD Prescription The staff member performing dialysis must remain within visual and auditory range of the patient/dialysis machine In patients without a blood prime, return the blood in the system per routine In children <20 kg, slow the blood flow rate by 50% while returning the blood to prevent acute hypertension In patients in whom a blood prime is used, do NOT return the blood in the system to the patient. Discard the entire setup with the blood in it to avoid acutely increasing the child's blood volume.

Summary Modality: No overall benefit to CRRT compared to IHD, though CRRT may be better for patients at risk of increased ICP and for volume control Dose: No benefit to “intensive” therapy, but delivered dose of both CRRT and IHD must be monitored to ensure minimum adequate dose Anticoagulation: Citrate is gaining wider acceptance as the preferred anticoagulation for CRRT Buffer: Bicarbonate should be the buffer in dialysate and replacement fluid for RRT in patients with AKI, especially with liver failure and/or lactic acidemia